Open
Actively Recruiting
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
About
Brief Summary
The purpose of this study is to compare the performance of Afirma GSC and ThyroSeq v.3 in indeterminate thyroid nodules to determine which test can allow more patients to avoid unnecessary surgery and preserve quality of life. In the initial phase of this study, the performance of Afirma GEC and ThyroSeq v.2 were compared.
Study Type
Phase
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Patients with a thyroid nodule who have a thyroid biopsy performed at UCLA health will be eligible for the study and consented if they agree to participate.
- Patients who have an indeterminate FNA biopsy result (Bethesda category 3 or 4) will be enrolled in the study if they agree to participate.
Exclusion Criteria:
- Patients who do not have an indeterminate biopsy result (either patients who have a benign, insufficient, or malignant result).
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
16-000055
Category
Head and Neck Cancer
Survivorship
Principal Investigator
Contact
Location
- UCLA Westwood